Evidence map›Paper›PMID 42040103›Full record

ArticleFrontiers in public health2026

Benchmarking public large language model responses to patient-facing inflammatory bowel disease questions: informational quality, transparency proxies, and readability.

Xiaoyue Wang, Chengguang Yin, Haiyang He, Jinjiao Guo, Xueting Fu, Feihu Bai

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaoyue Wang *Department of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Chengguang Yin *Department of Cardiology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Haiyang HeDepartment of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Jinjiao GuoDepartment of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Xueting FuDepartment of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Feihu BaiDepartment of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patient-facing large language model (LLM) outputs for inflammatory bowel disease (IBD) must be decision-relevant, readable, and verifiable. Methods: In a cross-sectional benchmark using a guideline-derived question set, five publicly available LLMs provided answers to 20 single-intent patient IBD questions, mapped to prespecified decision-critical domains across the care pathway (100 model-question responses). Queries were conducted from January 17-24, 2026, Results: Interrater agreement was high [DISCERN ICC(A,1) = 0.842; EQIP ICC(A,1) = 0.760; GQS weighted κ = 0.812; JAMA weighted κ = 0.936]. Median DISCERN scores ranged from 43.5 to 57.5, and EQIP scores ranged from 67.5 to 77.5, while transparency remained limited (JAMA median 0-1/4). Readability consistently failed to meet patient targets, with grade-level indices exceeding sixth grade and Flesch Reading Ease medians ranging from 15 to 36 (compared to a target of ≥80 for "easy" readability). All 10 outcomes varied significantly across models (Holm-adjusted Conclusion: Under default settings, publicly available LLMs exhibit variable informational quality for IBD but consistently poor transparency and readability. Patient-facing deployment should mandate provenance, currency, and disclosure fields, as well as outputs targeted to appropriate grade levels.

Indexed as

BenchmarkingComprehensionHealth LiteracyInflammatory Bowel DiseasesLarge Language ModelsCross-Sectional StudiesHumansbenchmarkinggenerative artificial intelligencehealth literacyinflammatory bowel diseaselarge language modelspatient-facingreadabilitytransparency

Identifiers

PMID42040103
PMCPMC13106179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.